EU regulators clear Pfizer's purchase of Hospira
European Union regulators on Tuesday approved Pfizer's $15.23 billion purchase of injectable drug and infusion device maker Hospira.
Aug 4, 2015
0
6
European Union regulators on Tuesday approved Pfizer's $15.23 billion purchase of injectable drug and infusion device maker Hospira.
Aug 4, 2015
0
6
A study of 311 patients by The University of Manchester has found that it may be possible to predict early which rheumatoid arthritis (RA) patients will fail to respond to the biologic drugs given to treat them. These findings ...
Jul 3, 2015
1
32
Two University of Florida researchers have invented a device that makes chemotherapy treatments more personalized, efficient and affordable.
Jul 2, 2015
0
125
In a population of Congo Basin foragers called the Aka, 67% of men—but only 6% of women—use cannabis, and the practice seems to protect against infection with parasitic worms.
Jun 1, 2015
0
3
The first national investigation of Medicare coverage of biologic disease modifying drugs (DMARDs) found that in starting a single biologic DMARD, patients face more than $2,700 in copayments each year before receiving relief ...
Apr 21, 2015
0
21
University of Notre Dame researchers led an international team to identify a molecular mechanism responsible for making malaria parasites resistant to artemisinins, the leading class of antimalarial drugs.
Apr 16, 2015
3
60
In the emerging biosimilar market, biosimilar antibodies are being developed to treat conditions currently addressed by their original, targeted biological therapy. Only a few biosimilars are approved by the EMA, and just ...
Apr 16, 2015
0
4
Clad in white lab coats, blue gloves and safety goggles, scientists are buzzing around a lab at Hospira in this suburb north of Chicago.
Mar 31, 2015
0
8
Use of the same antiangiogenesis drugs that have improved treatment of some cancers could also help surmount persistent difficulties in treating tuberculosis (TB). In their PNAS Early Edition report, investigators from Massachusetts ...
Jan 26, 2015
0
46
New research findings point toward a class of compounds that could be effective in combating infections caused by enterovirus D68, which has stricken children with serious respiratory infections and might be associated with ...
Jan 1, 2015
1
0